- Identify simple methods in statistical analyses used to demonstrate clinical trial outcomes
- Discuss study methodology in the context of evaluating study results for assessing clinical relevance
- Recognize common areas that differ between clinical trial data to aid in more precise interpretation of results
Interpreting Clinical Trial Data
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Learning Objectives
After this activity, the learner should be able to: Faculty and Disclosures
DISCLOSURE POLICY
DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:Leon Kircik, MD, FAAD; has had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: Aclaris Therapeutics, Almirall, S.A., Amgen Inc., Celgene, Dr. Reddy’s Laboratories, Innovail, ISDIN, Kamedis Dermatology, Leo Pharma, Inc., Merck & Co, Inc., Merz, Inc., Novartis, AG, Promius Pharma, LLC, PuraCap Pharmaceutical, Taro Pharmaceuticals Inc. and UCB, SA. Consultant/Advisory Board/Speakers Bureau: Allergan, Inc., Inc., Cipher Pharmaceuticals, Galderma Laboratories, LP, Genentech, Inc., Johnson & Johnson, Sun Pharmaceutical Industries, Inc., and Valeant Pharmaceuticals, Intl. Speakers Bureau: Amgen Inc., Innovail, L’Oreal, Taro Pharmaceuticals Inc. and UCB, SA. Grant/Research Support: Allergan, Inc., Amgen, Inc., Bayer HealthCare Pharmaceuticals, Boehringer Ingleheim, Celgene, Coherus Biosciences, Dermavant Sciences, Dermira, Inc., Dr. Reddy’s Laboratories, Eli Lilly, Galderma Laboratories, Genentech, Inc, Innovation Pharmaceuticals, Inc, Johnson & Johnson, Kamedis Dermatology, Leo Pharma, Inc., L’Oreal, Merck & Co, Inc., Novartis, AG,, Novan Pharmaceuticals, Obagi Cosmeceuticals, LLC., Promius Pharma, LLC., Pfzer, Inc., Sun Pharmaceutical Industries, Inc., UCB, SA, and Valeant Pharmaceuticals, Intl. ( Ortho Dermatologics). Stock Shareholder: Johnson & Johnson.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.The staff and planners from Evolve Medical Education and Physician Resources have no financial agreement or affiliations with commercial interests.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
0.50 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!